Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this consolidation of the drug supply chain could undercut competition.

Lawmakers should not ignore the concerns of Mississippi’s biggest employers as they wade into a national scrum over PBM ...